Understanding the pharmacokinetics of tulathromycin: a pulmonary perspective.
about
Comparison of Active Drug Concentrations in the Pulmonary Epithelial Lining Fluid and Interstitial Fluid of Calves Injected with Enrofloxacin, Florfenicol, Ceftiofur, or TulathromycinPharmacokinetics and pharmacodynamics of gamithromycin in pulmonary epithelial lining fluid in naturally occurring bovine respiratory disease in multisource commingled feedlot cattle.Standard PK/PD concepts can be applied to determine a dosage regimen for a macrolide: the case of tulathromycin in the calf.The influence of Actinobacillus pleuropneumoniae infection on tulathromycin pharmacokinetics and lung tissue disposition in pigs.Pharmacodynamic Evaluation and PK/PD-Based Dose Prediction of Tulathromycin: A Potential New Indication for Streptococcus suis Infection.Comparative efficacy of tulathromycin and tildipirosin for the treatment of experimental Mycoplasma bovis infection in calves.
P2860
Understanding the pharmacokinetics of tulathromycin: a pulmonary perspective.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Understanding the pharmacokinetics of tulathromycin: a pulmonary perspective.
@en
type
label
Understanding the pharmacokinetics of tulathromycin: a pulmonary perspective.
@en
prefLabel
Understanding the pharmacokinetics of tulathromycin: a pulmonary perspective.
@en
P2093
P2860
P356
P1476
Understanding the pharmacokinetics of tulathromycin: a pulmonary perspective.
@en
P2093
N Villarino
T Martín-Jiménez
P2860
P304
P356
10.1111/JVP.12080
P577
2013-09-30T00:00:00Z